Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Veltkamp

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
European Journal of Neurology|June 2, 2022
Levels and dynamics of estimated glomerular filtration rate and recurrent vascular events and death in patients with minor stroke or transient ischemic attackSerdar Tütüncü, Manuel C Olma, Claudia Kunze, et al.
The Lancet. Neurology|May 22, 2021
Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre studyKarl Georg Haeusler, Paulus Kirchhof, Claudia Kunze, et al.
Stroke|May 7, 2026
Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical TrialAshkan Shoamanesh, Stuart J Connolly, Andrew M Demchuk, et al.
Neurology|September 4, 2016
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysisDuncan Wilson, Andreas Charidimou, Gareth Ambler, et al.
The Lancet. Neurology|October 3, 2018
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trialScott E Kasner, Balakumar Swaminathan, Pablo Lavados, et al.
JAMA Neurology|October 19, 2020
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical TrialAshkan Shoamanesh, Robert G Hart, Stuart J Connolly, et al.
JAMA Neurology|July 7, 2020
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical TrialRoland Veltkamp, Lesly A Pearce, Eleni Korompoki, et al.
Stroke|August 22, 2013
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trialE Bernd Ringelstein, Vincent Thijs, Bo Norrving, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 12, 2022
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trialJonathan G Best, Liz Arram, Norin Ahmed, et al.
European Stroke Journal|September 9, 2022
Association of stroke lesion shape with newly detected atrial fibrillation - Results from the MonDAFIS studyBernardo Crespo Pimentel, Thies Ingwersen, Karl Georg Haeusler, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
European Journal of Neurology|June 2, 2022
Levels and dynamics of estimated glomerular filtration rate and recurrent vascular events and death in patients with minor stroke or transient ischemic attackSerdar Tütüncü, Manuel C Olma, Claudia Kunze, et al.
The Lancet. Neurology|May 22, 2021
Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre studyKarl Georg Haeusler, Paulus Kirchhof, Claudia Kunze, et al.
Stroke|May 7, 2026
Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical TrialAshkan Shoamanesh, Stuart J Connolly, Andrew M Demchuk, et al.
Neurology|September 4, 2016
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysisDuncan Wilson, Andreas Charidimou, Gareth Ambler, et al.
The Lancet. Neurology|October 3, 2018
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trialScott E Kasner, Balakumar Swaminathan, Pablo Lavados, et al.
JAMA Neurology|October 19, 2020
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical TrialAshkan Shoamanesh, Robert G Hart, Stuart J Connolly, et al.
JAMA Neurology|July 7, 2020
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical TrialRoland Veltkamp, Lesly A Pearce, Eleni Korompoki, et al.
Stroke|August 22, 2013
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trialE Bernd Ringelstein, Vincent Thijs, Bo Norrving, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 12, 2022
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trialJonathan G Best, Liz Arram, Norin Ahmed, et al.
European Stroke Journal|September 9, 2022
Association of stroke lesion shape with newly detected atrial fibrillation - Results from the MonDAFIS studyBernardo Crespo Pimentel, Thies Ingwersen, Karl Georg Haeusler, et al.
Pageof 20